References |
1 |
Pharmacokinetics and metabolism of midazolam in chimeric mice with humanised livers
|
2 |
The inhibition study of human UDP-glucuronosyltransferases with cytochrome P450 selective substrates and inhibitors
|
3 |
Contribution of the N-glucuronidation pathway to the overall in vitro metabolic clearance of midazolam in humans
|
4 |
The Oral Bioavailability and Metabolism of Midazolam in Stable Critically Ill Children: A Pharmacokinetic Microtracing Study
|
5 |
Heterotropic activation of the midazolam hydroxylase activity of CYP3A by a positive allosteric modulator of mGlu5: in vitro to in vivo translation and potential impact on clinically relevant drug-drug interactions
|